SPATA6
Spermatogenesis-associated protein 6
Also known as: FLJ10007, SPAT6_HUMAN, SRF-1, SRF1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NWH7
- Gene
- SPATA6
- Ensembl
- ENSG00000132122
- Chromosome
- 1
- Canonical length
- 488 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Vesicles
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
Predicted to enable myosin light chain binding activity. Predicted to be involved in motile cilium assembly and spermatogenesis. Predicted to be located in extracellular region and motile cilium. Predicted to be active in sperm head-tail coupling apparatus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
488 residues, UniProt reviewed canonical sequence.
>Q9NWH7|SPATA6
1 MPKVKALQCA LALEISSVTC PGVVLKDKED IYLSICVFGQ YKKTQCVPAT FPLVFNARMV
61 FEKVFPDAVD PGDVVTQLEY DTAVFELIQL VPPVGETLST YDENTRDFMF PGPNQMSGHH
121 DSNRQVTMRR ISGLRGNAPR LEFSTTSVIT ECLISSRKCH TQDKFIYHLA PVEKSHGRLQ
181 NRTSRSQKKK SKSPERSKYC INAKNYEQPT ISSKSHSPSP YTKRRMCELS EDTRRRLAHL
241 NLGPYEFKKE TDKPPFVIRH VDPPSPRADT LLGSSGRDCE RDGWSRVHND HSHLGCCRPK
301 DYKVIRTPHG RDFDDSLEKC EEYLSPRSCS KPRHSARTLL VHSAPSTMPK HSPSPVLNRA
361 SLRERFHSDW CSPSNCDEIH DRVKNVLKSH QAHQRHLYDE RDLEKDDELE LKRSLLCRDS
421 AYDSDPEYSS CQQPRGTFHL DDGEYWSNRA ASYKGKSHRP IFENSMDKMY RNLYKKACSS
481 ASHTQESFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SPATA6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 47 nTPM
Expression across tissuesHPA
Tissue
- testis: 47 nTPM
- fallopian tube: 14 nTPM
- retina: 12 nTPM
- parathyroid gland: 10 nTPM
- thyroid gland: 8.9 nTPM
- ovary: 8.5 nTPM
Single-cell type
- late spermatids: 6,642 nCPM
- early spermatids: 1,655 nCPM
- oligodendrocyte progenitor cells: 660 nCPM
- late primary spermatocytes: 548 nCPM
- ependymal cells: 437 nCPM
- bergmann glia: 429 nCPM
Immune cell
- non-classical monocyte: 5.9 nTPM
- eosinophil: 3.6 nTPM
- intermediate monocyte: 2.8 nTPM
- classical monocyte: 1.2 nTPM
- myeloid DC: 1.1 nTPM
- plasmacytoid DC: 0.5 nTPM
Brain region
- white matter: 26 nTPM
- basal ganglia: 21 nTPM
- thalamus: 21 nTPM
- medulla oblongata: 20 nTPM
- midbrain: 19 nTPM
- pons: 19 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.47
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.2
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SPATA6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SPATA6 as an antibody target. Whether an autoantibody or antibody against SPATA6 could matter depends on whether native SPATA6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SPATA6 is annotated as secreted, so native SPATA6 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label SPATA6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...